Clinical Trials Directory

Trials / Completed

CompletedNCT00944853

Effects of Liquid Zinc Supplementation and Dispersible Zinc Tablets on Plasma Zinc Concentration

The Effect of Zinc Supplementation, Provided as Either a Liquid Zinc Solution or Dispersible Tablets, on Plasma Zinc Concentration Among Young Burkinabe Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
462 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
6 Months – 23 Months
Healthy volunteers
Accepted

Summary

The study aims to compare the effects of two different formulations of zinc supplements on plasma zinc concentrations among young Burkinabe children.

Detailed description

1\) To investigate the effects of short-term zinc supplementation, provided either as a dispersible tablet containing zinc sulfate ("ZinCfant," Nutriset Ltd; Malaunay, France) or as a liquid ZnSO4 solution, on changes in serum zinc concentration, compared with a placebo in young Burkinabe children; and 2) to assess the relationship between change in serum zinc concentration and the presence of altered intestinal permeability within each treatment group.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLiquid zinc syrupLiquid zinc syrup containing 5 mg zinc as zinc sulfate
DIETARY_SUPPLEMENTZinc tabletDispersible zinc tablet containing 5 mg zinc
DIETARY_SUPPLEMENTLiquid placebo supplementLiquid placebo supplement containing 0 mg zinc

Timeline

Start date
2009-08-01
Primary completion
2009-12-01
Completion
2010-02-01
First posted
2009-07-23
Last updated
2017-02-24

Locations

1 site across 1 country: Burkina Faso

Source: ClinicalTrials.gov record NCT00944853. Inclusion in this directory is not an endorsement.